Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPageGroup Regulatory News (PAGE)

Share Price Information for PageGroup (PAGE)

Share Price is delayed by 15 minutes
Get Live Data
125.80    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 2.20 (1.774%)
Market Cap: £391.70m
PAGE Live PriceLast checked at - London Stock Exchange

Intraday PageGroup Share Chart

Holding(s) in Company

9 Feb 2017 13:04

RNS Number : 4720W
PageGroup plc
09 February 2017
 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

PageGroup Plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

X

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

Baillie Gifford & Co

 

4. Full name of shareholder(s)  (if different from 3.):iv

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

08 February 2017

6. Date on which issuer notified:

09 February 2017

7. Threshold(s) that is/are crossed orreached: vi, vii

5%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

Ordinary

Share

GB0030232317

 

 

16,512,860

 

 

16,512,860

Below 5%

Below 5%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

N/A

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

N/A

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

Below 5%

Below 5%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

In the narrative below, the figures in [ ] indicate the amount of voting rights and the percentage held by each controlled undertaking where relevant.

Baillie Gifford & Co, a discretionary investment manager, is the parent undertaking of an investment management group.

 Its wholly-owned subsidiary undertaking Baillie Gifford Overseas Limited [Below 5%] is also a discretionary investment manager.

Its wholly-owned subsidiary undertaking Baillie Gifford & Co Limited [Below 5%] is an OEIC Authorised Corporate Director and Unit Trust Manager which has delegated its discretionary investment management role to Baillie Gifford & Co.

Its wholly-owned subsidiary undertaking Baillie Gifford Life Limited [Below 5%] is a life assurance company which procures discretionary investment management services from Baillie Gifford & Co in respect of its own account shareholdings.

 

Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will cease to hold:

12. Date on which proxy holder will cease to hold voting rights:

13. Additional information:

14. Contact name:

Mike Bassi

15. Contact telephone number:

0131 275 3852

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLLLFIVFIIAIID
Date   Source Headline
28th May 20261:22 pmRNSResult of AGM
7th May 20263:00 pmRNSBoard change
14th Apr 20267:00 amRNSFIRST QUARTER 2026 TRADING UPDATE
13th Apr 202610:51 amRNSAnnual Report & Accounts & Notice of AGM
10th Apr 202612:34 pmRNSNotice of First Quarter 2026 Trading Update
30th Mar 20261:51 pmRNSDirector/PDMR Shareholding
19th Mar 20269:18 amRNSHolding(s) in Company
17th Mar 20269:44 amRNSDirector/PDMR Shareholding
16th Mar 202611:34 amRNSDirector/PDMR Shareholding
16th Mar 202611:34 amRNSDirector/PDMR Shareholding
13th Mar 20261:32 pmRNSDirector/PDMR Shareholding
9th Mar 20269:21 amRNSHolding(s) in Company
5th Mar 20261:22 pmRNSDirector/PDMR Shareholding
5th Mar 20267:00 amRNSFull Year Results for the Year Ended 31 Dec 2025
4th Mar 202611:43 amRNSPageGroup plc - Board Changes
2nd Mar 20262:58 pmRNSNotice of 2025 Full Year Results
17th Feb 202612:50 pmRNSHolding(s) in Company
10th Feb 20263:55 pmRNSDirector/PDMR Shareholding
13th Jan 20267:00 amRNSFOURTH QUARTER 2025 TRADING UPDATE
9th Jan 202610:23 amRNSNotice of Q4 and Full Year 2025 Trading Update
17th Dec 20252:17 pmRNSHolding(s) in Company
26th Nov 20259:38 amRNSHolding(s) in Company
24th Oct 202511:31 amRNSHolding(s) in Company
15th Oct 20257:00 amRNSTHIRD QUARTER 2025 TRADING UPDATE
13th Oct 202511:03 amRNSNotice of Third Quarter 2025 Trading Update
8th Oct 202511:31 amRNSHolding(s) in Company
12th Aug 20257:00 amRNSHalf Year Results for the Period Ended 30 June 25
7th Aug 20259:58 amRNSNotice of 2025 Half Year Results
10th Jul 20257:00 amRNSSecond Quarter 2025 Trading Update
8th Jul 20255:03 pmRNSNotice of Second Quarter 2025 Trading Update
11th Jun 202511:45 amRNSPageGroup plc - Board Changes
9th Jun 20254:11 pmRNSHolding(s) in Company
5th Jun 20257:00 amRNSAppointment of Joint Corporate Broker
4th Jun 202510:56 amRNSHolding(s) in Company
3rd Jun 20251:57 pmRNSResult of AGM
9th Apr 20257:00 amRNSFirst Quarter 2025 Trading Update
24th Mar 20252:02 pmRNSDirector Declaration
19th Mar 20251:18 pmRNSHolding(s) in Company
18th Mar 20251:41 pmRNSDirector/PDMR Shareholding
18th Mar 20251:35 pmRNSDirector/PDMR Shareholding
14th Mar 20251:10 pmRNSDirector/PDMR Shareholding
6th Mar 20257:00 amRNSFull Year Results for the Year Ended 31 Dec 2024
4th Mar 20259:40 amRNSNotice of 2024 Full Year Results
6th Feb 20259:44 amRNSDirector/PDMR Shareholding
13th Jan 20257:00 amRNSFourth Quarter 2024 Trading Update
9th Jan 20254:25 pmRNSNotice of Q4 and Full Year 2024 Trading Update
31st Oct 20243:37 pmRNSNotification of Interests of Directors
14th Oct 20247:00 amRNSThird Quarter 2024 Trading Update
10th Oct 202411:50 amRNSNotice of Third Quarter 2024 Trading Update
8th Aug 20247:00 amRNSHalf Year Results for the Period Ended 30 June 24

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.